# VPD-737 for Treatment of Chronic Pruritus

> **NCT01951274** · PHASE2 · COMPLETED · sponsor: **Vyne Therapeutics Inc.** · enrollment: 257 (actual)

## Conditions studied

- Chronic Pruritus

## Interventions

- **DRUG:** VPD-737
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01951274
- **Lead sponsor:** Vyne Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10-15
- **Primary completion:** 2014-12-02
- **Final completion:** 2014-12-02
- **Target enrollment:** 257 (ACTUAL)
- **Last updated:** 2022-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01951274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01951274, "VPD-737 for Treatment of Chronic Pruritus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01951274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*